Search research articles
Contact Us
Filters
Showing results (121-130 of 209) with videos related to
Page
of 21
Sort By:
Archives of Dermatological Research
|
January 1, 1993
Serum markers of collagen synthesis and degradation in skin diseases. Altered levels in diseases with systemic manifestation and during systemic glucocorticoid treatment
P Autio, J Risteli, U Kiistala, et al.
International Journal of Andrology
|
October 1, 1985
Laminin and type IV collagen in the human testis
P P Pöllänen, M Kallajoki, L Risteli, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1993
Impact of chemotherapy on collagen metabolism: a study of serum PIIINP (aminoterminal propeptide of type III procollagen) in advanced sarcomas
T A Wiklund, C P Blomqvist, L Risteli, et al.
Archives of Oral Biology
|
January 1, 1984
Immunohistochemical characterization of the basement membranes of the human oral mucosa
J Salonen, L J Pelliniemi, J M Foidart, et al.
The American Journal of Pathology
|
February 1, 1996
Expression of mRNAs for type I and type III procollagens in serous ovarian cystadenomas and cystadenocarcinomas
S Kauppila, J Saarela, F Stenbäck, et al.
British Journal of Cancer
|
January 1, 1996
Type I and type III collagen metabolites in adult osteosarcoma patients
T Wiklund, C Blomqvist, L Risteli, et al.
The American Journal of Surgical Pathology
|
June 1, 1988
Laminin and type IV collagen in different histological stages of Kaposi's sarcoma and other vascular lesions of blood vessel or lymphatic vessel origin
H Autio-Harmainen, T Karttunen, M Apaja-Sarkkinen, et al.
British Journal of Cancer
|
July 31, 1998
Aminoterminal propeptide of type I procollagen (PINP) correlates to bone loss and predicts the efficacy of antiresorptive therapy in pre- and post-menopausal non-metastatic breast cancer patients
T Saarto, C Blomqvist, J Risteli, et al.
British Journal of Cancer
|
January 1, 1997
Concomitant i.v. and oral clodronate in the relief of bone pain--a double-blind placebo-controlled study in patients with prostate cancer
T Kylmälä, T Taube, T L Tammela, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
February 1, 1993
Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry
E F Eriksen, P Charles, F Melsen, et al.
Page
of 21
Search research articles
Search
Showing results (121-130 of 209) with videos related to
Sort By:
Page
of 21
Archives of Dermatological Research
|
January 1, 1993
Serum markers of collagen synthesis and degradation in skin diseases. Altered levels in diseases with systemic manifestation and during systemic glucocorticoid treatment
P Autio, J Risteli, U Kiistala, et al.
International Journal of Andrology
|
October 1, 1985
Laminin and type IV collagen in the human testis
P P Pöllänen, M Kallajoki, L Risteli, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1993
Impact of chemotherapy on collagen metabolism: a study of serum PIIINP (aminoterminal propeptide of type III procollagen) in advanced sarcomas
T A Wiklund, C P Blomqvist, L Risteli, et al.
Archives of Oral Biology
|
January 1, 1984
Immunohistochemical characterization of the basement membranes of the human oral mucosa
J Salonen, L J Pelliniemi, J M Foidart, et al.
The American Journal of Pathology
|
February 1, 1996
Expression of mRNAs for type I and type III procollagens in serous ovarian cystadenomas and cystadenocarcinomas
S Kauppila, J Saarela, F Stenbäck, et al.
British Journal of Cancer
|
January 1, 1996
Type I and type III collagen metabolites in adult osteosarcoma patients
T Wiklund, C Blomqvist, L Risteli, et al.
The American Journal of Surgical Pathology
|
June 1, 1988
Laminin and type IV collagen in different histological stages of Kaposi's sarcoma and other vascular lesions of blood vessel or lymphatic vessel origin
H Autio-Harmainen, T Karttunen, M Apaja-Sarkkinen, et al.
British Journal of Cancer
|
July 31, 1998
Aminoterminal propeptide of type I procollagen (PINP) correlates to bone loss and predicts the efficacy of antiresorptive therapy in pre- and post-menopausal non-metastatic breast cancer patients
T Saarto, C Blomqvist, J Risteli, et al.
British Journal of Cancer
|
January 1, 1997
Concomitant i.v. and oral clodronate in the relief of bone pain--a double-blind placebo-controlled study in patients with prostate cancer
T Kylmälä, T Taube, T L Tammela, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
February 1, 1993
Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry
E F Eriksen, P Charles, F Melsen, et al.
Page
of 21